BIIB Biogen Inc.
$249.65▲ +2.29%
Healthcare
Other
Volume 1.16M
Avg Volume (10D) 1.41M
Key Metrics & Fundamentals
Market Cap
$36.90B
P/E Ratio
105.8
Div Yield
0.00%
52W Range
138.00 - 258.78
% vs 50 MA
10.32%
% vs 200 MA
24.36%
RSI-14
64.0
MACD Histogram
+1.1200
Beta (1Y vs SPY)
0.27
Free Cash Flow
$308.00M
Gross Rev
$2.74B
Gross Profit
$1.96B
EBITDA
$747.20M
COGS
$776.90M
Operating Exp
$1.48B
Operating Income
$482.80M
EBIT
$482.80M
Pretax Income
$132.40M
Net Income
$97.50M
EPS (Diluted)
0.66
Price & Volume History
Loading chart…
Recent News
Biogen Swings Back to Growth as Stock Momentum Could Continue, RBC Says
MT Newswires · Oct 29, 2026 11:58 AM ET
Bernstein Adjusts Price Target on Biogen to $278 From $236
MT Newswires · Oct 29, 2026 11:48 AM ET
UBS Adjusts Price Target on Biogen to $300 From $270, Keeps Buy Rating
MT Newswires · Oct 29, 2026 10:06 AM ET

Alphabet downgraded, eBay upgraded: Wall Street's top analyst calls
The Fly · Oct 29, 2026 9:47 AM ET
Argus Research Upgrades Biogen to Buy From Hold, $280 Price Target
MT Newswires · Oct 29, 2026 8:36 AM ET
RBC Raises Price Target on Biogen to $272 From $256, Keeps Outperform Rating
MT Newswires · Oct 29, 2026 7:01 AM ET

Biogen to Present New Data Across Alzheimer's Disease Portfolio at CTAD 2026
GlobeNewswire · Oct 29, 2026 6:59 AM ET

What to expect from Regeneron’s (REGN) Q3 earnings
StockStory · Oct 29, 2026 6:11 AM ET
Wedbush Adjusts Price Target on Biogen to $225 From $212, Maintains Neutral Rating
MT Newswires · Oct 29, 2026 5:23 AM ET

Biogen (BIIB) Stock Price Tracks Q3 Results Through Loss And Cash Flow
Simply Wall St. · Oct 29, 2026 1:18 AM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See BIIB's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.